Research programme: drug discovery - Takeda/Array

Drug Profile

Research programme: drug discovery - Takeda/Array

Latest Information Update: 06 Aug 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Array BioPharma; Takeda
  • Class Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Unspecified

Most Recent Events

  • 06 Aug 2009 Discontinued - Preclinical for Undefined indication in USA (unspecified route)
  • 13 Jun 2006 No development reported - Preclinical for Undefined in USA (unspecified route)
  • 31 Aug 2003 A series of small molecule compounds has been generated by Array
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top